Rezolute, Inc. (RZLT)
3.84
-0.11
(-2.78%)
USD |
NASDAQ |
Sep 18, 16:00
3.825
-0.02
(-0.39%)
After-Hours: 20:00
Rezolute 30-Day Average Daily Volume : 1.378M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.378M |
| September 17, 2026 | 1.324M |
| September 16, 2026 | 1.309M |
| September 15, 2026 | 1.325M |
| September 14, 2026 | 1.348M |
| September 11, 2026 | 1.346M |
| September 10, 2026 | 1.328M |
| September 09, 2026 | 1.281M |
| September 08, 2026 | 1.244M |
| September 04, 2026 | 1.257M |
| September 03, 2026 | 1.271M |
| September 02, 2026 | 1.317M |
| September 01, 2026 | 1.317M |
| August 31, 2026 | 1.331M |
| August 28, 2026 | 1.348M |
| August 27, 2026 | 1.348M |
| August 26, 2026 | 1.358M |
| August 25, 2026 | 1.337M |
| August 24, 2026 | 1.337M |
| August 21, 2026 | 1.375M |
| August 20, 2026 | 1.232M |
| August 19, 2026 | 1.247M |
| August 18, 2026 | 1.267M |
| August 17, 2026 | 1.288M |
| August 14, 2026 | 1.325M |
| Date | Value |
|---|---|
| August 13, 2026 | 1.396M |
| August 12, 2026 | 1.450M |
| August 11, 2026 | 1.483M |
| August 10, 2026 | 1.520M |
| August 07, 2026 | 1.714M |
| August 06, 2026 | 1.723M |
| August 05, 2026 | 1.782M |
| August 04, 2026 | 1.791M |
| August 03, 2026 | 1.810M |
| July 31, 2026 | 1.856M |
| July 30, 2026 | 1.933M |
| July 29, 2026 | 1.976M |
| July 28, 2026 | 2.029M |
| July 27, 2026 | 2.040M |
| July 24, 2026 | 2.037M |
| July 23, 2026 | 2.040M |
| July 22, 2026 | 2.047M |
| July 21, 2026 | 2.094M |
| July 20, 2026 | 2.116M |
| July 17, 2026 | 2.147M |
| July 16, 2026 | 2.285M |
| July 15, 2026 | 2.475M |
| July 14, 2026 | 2.501M |
| July 13, 2026 | 2.491M |
| July 10, 2026 | 2.439M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 4.434M |
| Avalo Therapeutics, Inc. | 928495.0 |
| Opus Genetics, Inc. | 3.584M |
| ACADIA Pharmaceuticals, Inc. | 1.577M |
| Alnylam Pharmaceuticals, Inc. | 1.660M |